Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?

BACKGROUND/AIMS: Nonselective β-blockers (NSBBs), such as propranolol, reportedly exert a pleiotropic effect in liver cirrhosis. A previous report suggested that survival was higher in patients receiving adjusted doses of NSBBs than in ligation patients. This study investigated whether low-dose NSBB...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kim, Tae Wan, Kim, Hong Joo, Chon, Chang Uk, Won, Hyun Sun, Park, Jung Ho, Park, Dong Il, Cho, Yong Kyun, Sohn, Chong Il, Jeon, Woo Kyu, Kim, Byung Ik
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Association for the Study of the Liver 2012
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3415875/
https://ncbi.nlm.nih.gov/pubmed/22893871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2012.18.2.203
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak